Based on recent data, Vir Biotechnology, Inc. (VIR) shows an Average True Range (ATR) of 0.73 and an Enterprise Value of 961.88M. Its average trading volume over the past 3 months is 1.87M, indicating liquidity. These fundamental metrics provide insight into VIR's underlying financial health and market activity.
| ATR | 0.73 |
| Enterprise Value | 961.88M |
| Avg Vol (3 Months) | 1.87M |
| Avg Vol (10 Days) | 1.49M |
Vir Biotechnology, Inc. (VIR) technical indicators as of June 11, 2026: the SMA 20 is 19.06%, SMA 50 at 34.25%, and SMA 200 at 61.64%. The RSI 14 value is 66.17, suggesting its current momentum. These technical analysis signals help assess VIR's price trends and potential future movements.
| SMA 20 | 19.06% |
| SMA 50 | 34.25% |
| SMA 200 | 61.64% |
| RSI 14 | 66.17 |
Vir Biotechnology, Inc. (VIR) stock performance overview as of June 11, 2026: The 52-week high is $11.66 (currently -14.81% below), and the 52-week low is $4.16 (currently 124.31% above). Over the past year, VIR's performance is -40.3%, compared to the S&P 500's 9.37% change.
| 52-Week High | 11.66 |
| 52-Week High Chg | -14.81% |
| 52-Week Low | 4.16 |
| 52-Week Low Chg | +124.31% |
| S&P 500 52-Week Chg | 9.37% |
According to market data, Vir Biotechnology, Inc. (VIR) stock's recent performance metrics show that over the last month, VIR is -2.28%, with a Year-to-Date (YTD) performance of -0.5%. Over the past year, the stock has seen a -40.3% change. These figures summarize VIR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 9.29 | 9.91 | 11.66 | 11.66 | 11.66 | 11.66 |
| Low | 8.16 | 8.16 | 8.16 | 5.45 | 4.16 | 5.55 |
| Performance | +1.35% | -2.28% | +3.81% | +8.70% | -40.30% | -0.50% |
According to current financial data, VIR stock's P/E (TTM) ratio is -2.73, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for VIR, including P/S (21.13), P/B (1.49), and P/FCF (-3.11), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VIR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.73 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 21.13 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 1.49 | 0 | 10.92 | 5.27 |
| P/FCF (TTM) | -3.11 | 5.09 | -912.14 | 29.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep